Avadel Pharmaceuticals (AWK.F) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.28
-0.2
-0.11
-0.03

Details

Expected EPS
-0.033351110680000004
Actual EPS
-0.0476935
Surprise EPS
-0.01
Surprise Percent
+43%

Description

Avadel Pharmaceuticals (AWK.F) has reported earnings of -0.0476935 per share for Q1 2025.

0 Comments

Share your thoughts